In a mouse model of prostate cancer (myc-CaP), Ammirante et al. [93] demonstrated that castration of myc-CaP tumor-bearing mice results in the accumulation of an immune infiltrate comprised of B and T lymphocytes, NK cells, and myeloid cells in dying androgen-deprived primary tumors. This evidence concerns the gene MYC and prostate cancer.